Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05745493 · ClinicalTrials.gov registry record · NA

Study 1: Social Engage Coaching R61 Phase

A NA study of Quality of Life and Loneliness, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT05745493: Completed NA study of Quality of Life and Loneliness, sponsored by University of Rochester.

NCT05745493 is a NA study of Quality of Life and Loneliness that has completed, run by University of Rochester. The registered enrollment target is 29 participants, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05745493, a NA study of Quality of Life and Loneliness, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test whether an individual coaching program called Social Engage Coaching (or 'Engage Coaching' for short) helps adults age 60 and older feel more connected to other people in ways that matter to them. Procedures include participating in a Social Engage Coaching program, research assessments with surveys, and assessments completed on a cell phone. Engage Coaching involves individual sessions with a trained Engage Coach (up to 10 sessions) that are designed to help participants improve social relationships and well-being. All subjects will receive the scheduled baseline and follow-up interviews by the research team. These interviews will be conducted at study start, mid-way through the program at 8 weeks and after completing the program at 16 weeks. Interviews will be via Zoom/phone as well as surveys done online.

Primary Outcome

PROMIS Social Isolation Short Form 4a assessed by Ecological Momentary Assessment (EMA) on smartphones

Interventions

  • BEHAVIORAL Social Engage Coaching (S-ENG)

Study Locations (1)

New York

  • University of Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2023-06-13
Est. Completion 2025-09-30
Phase NA
University of Rochester

636 total trials

What the finished NCT05745493 record still lists

NCT05745493 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (94% lower).

The record links to 4 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which Social Engage Coaching (S-ENG) is the first listed.

NCT05745493 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05745493 about?

NCT05745493 is a clinical study titled "Study 1: Social Engage Coaching R61 Phase". The purpose of this study is to test whether an individual coaching program called Social Engage Coaching (or 'Engage Coaching' for short) helps adults age 60 and older feel more connected to other people in ways that matter to them. Procedures include participating in a Social Engage Coaching progr...

What is the current status of trial NCT05745493?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2023-06-13. Estimated completion is 2025-09-30.

What conditions does trial NCT05745493 study?

This clinical trial studies the following conditions: Quality of Life, Loneliness, Social Isolation, Suicide Ideation.

What interventions are being tested in trial NCT05745493?

The interventions under investigation include: Social Engage Coaching (S-ENG) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05745493?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05745493 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05745493's enrollment target sits among peer trials

29 93rd of 107 higher than 15 of 107 other Quality of Life trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05745493, the US trial registry maintained by the National Library of Medicine. NCT05745493 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.